TY - JOUR
T1 - Enhancement of nitric oxide production after arterial reconstruction in patients with arteriosclerosis obliterans
AU - Komori, K.
AU - matsumoto, takuya
AU - Ishida, M.
AU - Kuma, S.
AU - Yonemitsu, Y.
AU - Eguchi, D.
AU - Sugimachi, K.
N1 - Funding Information:
Supported in part by a Grant-in-Aid for General Scientific Research from the Ministry of Education, Science, and Culture of Japan.
PY - 1997
Y1 - 1997
N2 - Purpose: Nitric oxide (NO) not only relaxes vascular smooth muscles, but it also reduces platelet adhesion and is itself a potent antiaggregatory substance. Experimental studies have shown that the release of NO is modulated by the blood flow. However, little clinical information is available about the effects of hemodynamic changes after arterial reconstruction on NO production. We therefore examined whether the plasma levels of nitrite (NO2-) and nitrate (NO3-) ions increased after arterial reconstruction in patients with arteriosclerosis obliterans (ASO). Methods: Blood samples were obtained from the femoral artery in seven patients who underwent arterial reconstruction and seven healthy individuals (control). NO2- and NO3- levels were measured using high-performance liquid chromatography before the operation and 1 hour and 14 days after the operation. In addition, the mean femoral artery blood flow and ankle-brachial pressure index (ABI) were also measured using a duplex and Doppler velocimeter both before and after the operations. Results: In the control subjects, the mean plasma NO2-, NO2-, and NO(X) (NO2- plus NO3-) levels in the femoral artery were 0.57 ± 0.15 μmol/L, 45.6 ± 10.8 μmol/L, and 46.0 ± 10.9 μmol/L, respectively. Before the operation in the patients with ASO, the mean plasma NO3- (23.8 ± 2.2 μmol/L) and NO(X) levels (24.0 ± 2.3 μml/L) were significantly lower than those in the control subjects, whereas the plasma NO2- levels (0.27 ± 0.04 μmol/L) were comparable between the two groups. At 14 days after operation, the mean plasma NO3- and NO(X) levels in the femoral artery were significantly increased to 42.8 ± 5.6 μmol/L and 43.4 ± 5.6 μmol/L compared with those before the operation, whereas the mean plasma NO2- levels (0.50 ± 0.05 μmol/L) changed significantly. The mean ABI and the mean flow rate before the operation were 0.32 ± 0.07 and 344 ± 145 ml/min, respectively. Both the ABI and the mean flow rate significantly increased to 1.04 ± 0.06 and 627 ± 141 ml/min after the operation. Conclusions: In patients who have ASO, the mean plasma level of NO is significantly lower than that of healthy individuals. In patients with ASO, the mean blood flow increased significantly after arterial reconstruction. This hemodynamic improvement may thus enhance NO production and may also help to maintain the patency of the bypass graft or native artery.
AB - Purpose: Nitric oxide (NO) not only relaxes vascular smooth muscles, but it also reduces platelet adhesion and is itself a potent antiaggregatory substance. Experimental studies have shown that the release of NO is modulated by the blood flow. However, little clinical information is available about the effects of hemodynamic changes after arterial reconstruction on NO production. We therefore examined whether the plasma levels of nitrite (NO2-) and nitrate (NO3-) ions increased after arterial reconstruction in patients with arteriosclerosis obliterans (ASO). Methods: Blood samples were obtained from the femoral artery in seven patients who underwent arterial reconstruction and seven healthy individuals (control). NO2- and NO3- levels were measured using high-performance liquid chromatography before the operation and 1 hour and 14 days after the operation. In addition, the mean femoral artery blood flow and ankle-brachial pressure index (ABI) were also measured using a duplex and Doppler velocimeter both before and after the operations. Results: In the control subjects, the mean plasma NO2-, NO2-, and NO(X) (NO2- plus NO3-) levels in the femoral artery were 0.57 ± 0.15 μmol/L, 45.6 ± 10.8 μmol/L, and 46.0 ± 10.9 μmol/L, respectively. Before the operation in the patients with ASO, the mean plasma NO3- (23.8 ± 2.2 μmol/L) and NO(X) levels (24.0 ± 2.3 μml/L) were significantly lower than those in the control subjects, whereas the plasma NO2- levels (0.27 ± 0.04 μmol/L) were comparable between the two groups. At 14 days after operation, the mean plasma NO3- and NO(X) levels in the femoral artery were significantly increased to 42.8 ± 5.6 μmol/L and 43.4 ± 5.6 μmol/L compared with those before the operation, whereas the mean plasma NO2- levels (0.50 ± 0.05 μmol/L) changed significantly. The mean ABI and the mean flow rate before the operation were 0.32 ± 0.07 and 344 ± 145 ml/min, respectively. Both the ABI and the mean flow rate significantly increased to 1.04 ± 0.06 and 627 ± 141 ml/min after the operation. Conclusions: In patients who have ASO, the mean plasma level of NO is significantly lower than that of healthy individuals. In patients with ASO, the mean blood flow increased significantly after arterial reconstruction. This hemodynamic improvement may thus enhance NO production and may also help to maintain the patency of the bypass graft or native artery.
UR - http://www.scopus.com/inward/record.url?scp=0030727948&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030727948&partnerID=8YFLogxK
U2 - 10.1016/S0741-5214(97)70066-1
DO - 10.1016/S0741-5214(97)70066-1
M3 - Article
C2 - 9357468
AN - SCOPUS:0030727948
VL - 26
SP - 657
EP - 662
JO - Journal of Vascular Surgery
JF - Journal of Vascular Surgery
SN - 0741-5214
IS - 4
ER -